MapLight Therapeutics, Inc.
Price Action
Technical Summary
CONSOLIDATINGMapLight Therapeutics, Inc. is in a consolidation phase, trading with mixed signals as moving averages converge. Relative strength is leading (RS Rating: 82), indicating clear outperformance against the broad market. Earnings contraction of 54% provides fundamental context to the price action. Investors should exercise caution due to high volatility (90% annualized), which requires wider risk management.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $29.59 | -2.91% | BELOW |
| 50 SMA | $24.64 | +16.59% | ABOVE |
| 100 SMA | $21.17 | +35.69% | ABOVE |
| 150 SMA | $— | — | |
| 200 SMA | $— | — |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is MPLT in an uptrend right now?
MPLT has a trend score of 2/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 2 of 4 trend criteria are met.
Is MPLT overbought or oversold?
MPLT's RSI (14) is 54. The stock is in neutral territory, neither overbought nor oversold.
Is MPLT outperforming the market?
MPLT has a Relative Strength (RS) Rating of 82 out of 99. Yes, MPLT is a market leader, outperforming 82% of all stocks over the past 12 months.
Where is MPLT in its 52-week range?
MPLT is trading at $28.73, which is 86% of its 52-week high ($33.28) and 73% above its 52-week low ($16.34).
How volatile is MPLT?
MPLT has a Beta of N/A and 52-week volatility of 90%. It moves roughly in line with the overall market.